Skip to main content
Top
Published in: Journal of Cancer Survivorship 3/2015

01-09-2015

Screening and comorbidity of clinical levels of fear of cancer recurrence

Authors: Sébastien Simard, Josée Savard

Published in: Journal of Cancer Survivorship | Issue 3/2015

Login to get access

Abstract

Purpose

The prevalence of clinical levels of fear of cancer recurrence (FCR) in cancer survivors is unknown, which may be partly explained by the lack of an assessment method that would make it possible to distinguish between normal and clinical levels of FCR. Moreover, despite the apparent overlap between FCR and manifestations of some psychiatric disorders, no study has yet evaluated the comorbidity of clinical levels of FCR. The goals of this study were to assess the capacity of the Fear of Cancer Recurrence Inventory severity subscale, to consider a shorter form of the FCRI (FCRI-SF), to screen for clinical levels of FCR, and to assess its psychiatric comorbidity.

Methods

Sixty French-Canadian cancer survivors (73 % of those eligible) who had been treated within the past 4 years for localized breast, prostate, lung, or colorectal cancer were randomly selected. Participants were administered a clinical interview assessing FCR, the Structured Clinical Interview for DSM-IV, and self-report scales.

Results

A cutoff score of 13 or higher on the FCRI-SF was associated with optimal sensitivity (88 %) and specificity (75 %) rates for the screening of clinical levels of FCR. Cancer survivors with clinical levels of FCR were significantly more likely to meet the criteria for a current psychiatric disorder (60 %) than patients with nonclinical levels (29 %). Anxiety disorders tended to be the most common comorbid disorders.

Conclusions/Implications for Cancer Survivors

The FCRI-SF allows rapid and effective screening of clinical levels of FCR, a condition associated with significant psychiatric comorbidity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vickberg SMJ. The Concerns About Recurrence Scale (CARS): a systematic measure of women’s fears about the possibily of breast cancer reccurrence. Ann Behav Med. 2003;25(1):16–24.CrossRefPubMed Vickberg SMJ. The Concerns About Recurrence Scale (CARS): a systematic measure of women’s fears about the possibily of breast cancer reccurrence. Ann Behav Med. 2003;25(1):16–24.CrossRefPubMed
2.
go back to reference Baker F, Denniston M, Smith T, West MM. Adult cancer survivors: how are they faring? Cancer. 2005;104(11 Suppl):2565–76.CrossRefPubMed Baker F, Denniston M, Smith T, West MM. Adult cancer survivors: how are they faring? Cancer. 2005;104(11 Suppl):2565–76.CrossRefPubMed
3.
go back to reference Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7(3):300–22.CrossRefPubMed Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7(3):300–22.CrossRefPubMed
4.
go back to reference LeeJones C, Humphris G, Dixon R, Hatcher MB. Fear of cancer recurrence—a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology. 1997;6(2):95–105.CrossRef LeeJones C, Humphris G, Dixon R, Hatcher MB. Fear of cancer recurrence—a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology. 1997;6(2):95–105.CrossRef
5.
go back to reference Koch L, Jansen L, Brenner H, Arndt V. Fear of recurrence and disease progression in long‐term (≥5 years) cancer survivors—a systematic review of quantitative studies. Psychooncology. 2013;22(1):1–11.CrossRefPubMed Koch L, Jansen L, Brenner H, Arndt V. Fear of recurrence and disease progression in long‐term (≥5 years) cancer survivors—a systematic review of quantitative studies. Psychooncology. 2013;22(1):1–11.CrossRefPubMed
6.
go back to reference Crist JV, Grunfeld EA. Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psychooncology. 2013;22(5):978–86.CrossRefPubMed Crist JV, Grunfeld EA. Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psychooncology. 2013;22(5):978–86.CrossRefPubMed
7.
go back to reference Humphris GM, Rogers S, McNally D, Lee-Jones C, Brown J, Vaughan D. Fear of recurrence and possible cases of anxiety and depression in orofacial cancer patients. Int J Oral Maxillofac Surg. 2003;32(5):486–91.CrossRefPubMed Humphris GM, Rogers S, McNally D, Lee-Jones C, Brown J, Vaughan D. Fear of recurrence and possible cases of anxiety and depression in orofacial cancer patients. Int J Oral Maxillofac Surg. 2003;32(5):486–91.CrossRefPubMed
8.
go back to reference Mast ME. Survivors of breast cancer: illness uncertainty, positive reappraisal, and emotional distress. Oncol Nurs Forum. 1998;25(3):555–62.PubMed Mast ME. Survivors of breast cancer: illness uncertainty, positive reappraisal, and emotional distress. Oncol Nurs Forum. 1998;25(3):555–62.PubMed
9.
go back to reference Koch L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, et al. Fear of recurrence in long-term breast cancer survivors—still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the Cancer Survivorship—a multi-regional population-based study. Psychooncology. 2014;23(5):547–54.CrossRefPubMed Koch L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, et al. Fear of recurrence in long-term breast cancer survivors—still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the Cancer Survivorship—a multi-regional population-based study. Psychooncology. 2014;23(5):547–54.CrossRefPubMed
10.
go back to reference Hart SL, Latini DM, Cowan JE, Carroll PR. Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer. Support Care Cancer. 2008;16(2):161–9.CrossRefPubMed Hart SL, Latini DM, Cowan JE, Carroll PR. Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer. Support Care Cancer. 2008;16(2):161–9.CrossRefPubMed
11.
go back to reference Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17(3):241–51.CrossRefPubMed Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17(3):241–51.CrossRefPubMed
12.
go back to reference Thewes B, Butow P, Zachariae R, Christensen S, Simard S, Gotay C. Fear of cancer recurrence: a systematic literature review of self-report measures. Psychooncology. 2012;21(6):571–87.CrossRefPubMed Thewes B, Butow P, Zachariae R, Christensen S, Simard S, Gotay C. Fear of cancer recurrence: a systematic literature review of self-report measures. Psychooncology. 2012;21(6):571–87.CrossRefPubMed
13.
go back to reference Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-IV (SCID). New York: Biometrics Research Department, New-York State Psychiatric Institute; 1997. Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-IV (SCID). New York: Biometrics Research Department, New-York State Psychiatric Institute; 1997.
14.
go back to reference Antony MM, Rowa K. Evidence-based assessment of anxiety disorders in adults. Psychol Assess. 2005;17(3):256–66.CrossRefPubMed Antony MM, Rowa K. Evidence-based assessment of anxiety disorders in adults. Psychol Assess. 2005;17(3):256–66.CrossRefPubMed
15.
go back to reference Hogan TP. Psychological testing: a practical introduction, 2nd ed. Hoboken; 2007. Hogan TP. Psychological testing: a practical introduction, 2nd ed. Hoboken; 2007.
16.
go back to reference Davison TE, McCabe MP, Mellor D. An examination of the “gold standard” diagnosis of major depression in aged-care settings. Am J Geriatr Psychiatr. 2009;17(5):359–67.CrossRef Davison TE, McCabe MP, Mellor D. An examination of the “gold standard” diagnosis of major depression in aged-care settings. Am J Geriatr Psychiatr. 2009;17(5):359–67.CrossRef
17.
go back to reference Ma X, Zhang J, Zhong W, Shu C, Wang F, Wen J, et al. The diagnostic role of a short screening tool-the distress thermometer: a meta-analysis. Support Care Cancer. 2014;22(7):1741–55.CrossRefPubMed Ma X, Zhang J, Zhong W, Shu C, Wang F, Wen J, et al. The diagnostic role of a short screening tool-the distress thermometer: a meta-analysis. Support Care Cancer. 2014;22(7):1741–55.CrossRefPubMed
18.
go back to reference Murphy JM, Berwick DM, Weinstein MC, Borus JF, Budman SH, Klerman GL. Performance of screening and diagnostic tests. Application of receiver operating characteristic analysis. Arch Gen Psychiatr. 1987;44(6):550–5.CrossRefPubMed Murphy JM, Berwick DM, Weinstein MC, Borus JF, Budman SH, Klerman GL. Performance of screening and diagnostic tests. Application of receiver operating characteristic analysis. Arch Gen Psychiatr. 1987;44(6):550–5.CrossRefPubMed
19.
go back to reference Zwahlen D, Hagenbuch N, Carley MI, Recklitis CJ, Buchi S. Screening cancer patients’ families with the distress thermometer (DT): a validation study. Psychooncology. 2008;17(10):959–66.CrossRefPubMed Zwahlen D, Hagenbuch N, Carley MI, Recklitis CJ, Buchi S. Screening cancer patients’ families with the distress thermometer (DT): a validation study. Psychooncology. 2008;17(10):959–66.CrossRefPubMed
20.
go back to reference Skaali T, Fossa SD, Bremnes R, Dahl O, Haaland CF, Hauge ER, et al. Fear of recurrence in long-term testicular cancer survivors. Psychooncology. 2009;18(6):580–8.CrossRefPubMed Skaali T, Fossa SD, Bremnes R, Dahl O, Haaland CF, Hauge ER, et al. Fear of recurrence in long-term testicular cancer survivors. Psychooncology. 2009;18(6):580–8.CrossRefPubMed
21.
go back to reference Mirabeau-Beale KL, Kornblith AB, Penson RT, Lee H, Goodman A, Campos SM, et al. Comparison of the quality of life of early and advanced stage ovarian cancer survivors. Gynecol Oncol. 2009;114(2):353–9.CrossRefPubMed Mirabeau-Beale KL, Kornblith AB, Penson RT, Lee H, Goodman A, Campos SM, et al. Comparison of the quality of life of early and advanced stage ovarian cancer survivors. Gynecol Oncol. 2009;114(2):353–9.CrossRefPubMed
22.
go back to reference Matulonis UA, Kornblith A, Lee H, Bryan J, Gibson C, Wells C, et al. Long-term adjustment of early-stage ovarian cancer survivors. Int J Gynecol Cancer. 2008;18(6):1183–93.CrossRefPubMed Matulonis UA, Kornblith A, Lee H, Bryan J, Gibson C, Wells C, et al. Long-term adjustment of early-stage ovarian cancer survivors. Int J Gynecol Cancer. 2008;18(6):1183–93.CrossRefPubMed
23.
go back to reference Mehnert A, Berg P, Henrich G, Herschbach P. Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psychooncology. 2009;18(12):1273–80.CrossRefPubMed Mehnert A, Berg P, Henrich G, Herschbach P. Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psychooncology. 2009;18(12):1273–80.CrossRefPubMed
24.
go back to reference Roth A, Nelson CJ, Rosenfeld B, Warshowski A, O’Shea N, Scher H, et al. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics. 2006;47(4):340–7.CrossRefPubMed Roth A, Nelson CJ, Rosenfeld B, Warshowski A, O’Shea N, Scher H, et al. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics. 2006;47(4):340–7.CrossRefPubMed
25.
go back to reference Simard S, Savard J, Ivers H. Fear of cancer recurrence: specific profiles and nature of intrusive thoughts. J Cancer Surviv. 2010;4(4):361–71.CrossRefPubMed Simard S, Savard J, Ivers H. Fear of cancer recurrence: specific profiles and nature of intrusive thoughts. J Cancer Surviv. 2010;4(4):361–71.CrossRefPubMed
26.
go back to reference Liu Y, Perez M, Schootman M, Aft RL, Gillanders WE, Jeffe DB. Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat. 2011;130(1):165–73.PubMedCentralCrossRefPubMed Liu Y, Perez M, Schootman M, Aft RL, Gillanders WE, Jeffe DB. Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat. 2011;130(1):165–73.PubMedCentralCrossRefPubMed
28.
go back to reference American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Texte revision. 4th ed. Washington: American Psychiatric Association; 2000. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Texte revision. 4th ed. Washington: American Psychiatric Association; 2000.
29.
go back to reference Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.CrossRefPubMed Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.CrossRefPubMed
30.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Nat Cancer Inst. 1993;85(5):365–76.CrossRefPubMed Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Nat Cancer Inst. 1993;85(5):365–76.CrossRefPubMed
31.
go back to reference Tabachnik BG, Fidell LS. Using multivariate statistics. 4th ed. New York: Harper Collins Publishers; 2001. Tabachnik BG, Fidell LS. Using multivariate statistics. 4th ed. New York: Harper Collins Publishers; 2001.
32.
go back to reference SPSS. Statistical package for the social sciences. Chicago: SPSS Corporation; 1999. SPSS. Statistical package for the social sciences. Chicago: SPSS Corporation; 1999.
33.
go back to reference Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther. 2005;85(3):257–68.PubMed Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther. 2005;85(3):257–68.PubMed
35.
go back to reference Zhou XH, Obuchowski NA, McClish DK. Statitistic methods in diagnostic medicine. New York: Wiley; 2002.CrossRef Zhou XH, Obuchowski NA, McClish DK. Statitistic methods in diagnostic medicine. New York: Wiley; 2002.CrossRef
36.
go back to reference Fombonne E, Fuhrer R. L’application de l’analyse ROC en psychiatrie. Encéphale. 1995;18:545–50. Fombonne E, Fuhrer R. L’application de l’analyse ROC en psychiatrie. Encéphale. 1995;18:545–50.
37.
go back to reference Obuchowski NA, Lieber ML, Wians Jr FH. ROC curves in clinical chemistry: uses, misuses, and possible solutions. Clin Chem. 2004;50(7):1118–25.CrossRefPubMed Obuchowski NA, Lieber ML, Wians Jr FH. ROC curves in clinical chemistry: uses, misuses, and possible solutions. Clin Chem. 2004;50(7):1118–25.CrossRefPubMed
38.
go back to reference Custers JA, van den Berg SW, van Laarhoven HW, Bleiker EM, Gielissen MF, Prins JB. The Cancer Worry Scale: detecting fear of recurrence in breast cancer survivors. Cancer Nurs. 2014;37(1):E44–50.CrossRefPubMed Custers JA, van den Berg SW, van Laarhoven HW, Bleiker EM, Gielissen MF, Prins JB. The Cancer Worry Scale: detecting fear of recurrence in breast cancer survivors. Cancer Nurs. 2014;37(1):E44–50.CrossRefPubMed
39.
go back to reference Thewes B, Zachariae R, Christensen S, Nielsen T, Butow P. The concerns about recurrence questionnaire: validation of a brief measure of fear of cancer recurrence amongst Danish and Australian breast cancer survivors. J Cancer Surviv 2014. Thewes B, Zachariae R, Christensen S, Nielsen T, Butow P. The concerns about recurrence questionnaire: validation of a brief measure of fear of cancer recurrence amongst Danish and Australian breast cancer survivors. J Cancer Surviv 2014.
40.
go back to reference Deimling GT, Bowman KF, Sterns S, Wagner LJ, Kahana B. Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psychooncology. 2006;15(4):306–20.CrossRefPubMed Deimling GT, Bowman KF, Sterns S, Wagner LJ, Kahana B. Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psychooncology. 2006;15(4):306–20.CrossRefPubMed
41.
go back to reference Gil KM, Mishel M, Belyea M, Germino B, Germino LS, Porter L, et al. Triggers of uncertainty about recurrence and long-term treatment side effects in older African American and Caucasian breast cancer survivors. Oncol Nurs Forum. 2004;31(3):633–9.CrossRef Gil KM, Mishel M, Belyea M, Germino B, Germino LS, Porter L, et al. Triggers of uncertainty about recurrence and long-term treatment side effects in older African American and Caucasian breast cancer survivors. Oncol Nurs Forum. 2004;31(3):633–9.CrossRef
42.
go back to reference Thewes B, Bell ML, Butow P, Beith J, Boyle F, Friedlander M, et al. Psychological morbidity and stress but not social factors influence level of fear of cancer recurrence in young women with early breast cancer: results of a cross‐sectional study. Psychooncology. 2013;22(12):2797–806.CrossRefPubMed Thewes B, Bell ML, Butow P, Beith J, Boyle F, Friedlander M, et al. Psychological morbidity and stress but not social factors influence level of fear of cancer recurrence in young women with early breast cancer: results of a cross‐sectional study. Psychooncology. 2013;22(12):2797–806.CrossRefPubMed
43.
go back to reference Butow PN, Bell ML, Smith AB, Fardell JE, Thewes B, Turner J, et al. Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence. BMC Cancer. 2013;13:201.PubMedCentralCrossRefPubMed Butow PN, Bell ML, Smith AB, Fardell JE, Thewes B, Turner J, et al. Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence. BMC Cancer. 2013;13:201.PubMedCentralCrossRefPubMed
44.
go back to reference American Psychiatric A. Diagnostic and statistical manual of mental disorders DSM-5. Arlington: American Psychiatric Association; 2013. American Psychiatric A. Diagnostic and statistical manual of mental disorders DSM-5. Arlington: American Psychiatric Association; 2013.
Metadata
Title
Screening and comorbidity of clinical levels of fear of cancer recurrence
Authors
Sébastien Simard
Josée Savard
Publication date
01-09-2015
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 3/2015
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-015-0424-4

Other articles of this Issue 3/2015

Journal of Cancer Survivorship 3/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine